↓ Skip to main content

A phase II trial protocol of Tocilizumab in anti-TNF refractory patients with JIA-associated uveitis (the APTITUDE trial)

Overview of attention for article published in BMC Rheumatology, February 2018
Altmetric Badge

Mentioned by

twitter
3 X users

Citations

dimensions_citation
27 Dimensions

Readers on

mendeley
44 Mendeley